Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pasireotide LAR vs Octreotide LAR in Active Acromegaly
NCT00600886Phase 3Completed
- Sponsor
- Novartis
- Start
- Feb 2008
- Primary completion
- Mar 2016
- Modality
- Peptides, Small Molecules
- Countries
- 27
01
Overview
A Phase 3 trial of pasireotide LAR in acromegaly, sponsored by Novartis. Started Feb 2008; status: completed.
02
Drugs
pasireotide LAR
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT00600886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00600886.